Shareholders Voted to Approve Both SAIF Partners Proposals at Special Meeting
Newly Elected Directors Are Committed to Support and Execute the Announced Payout of Dividends and Unlock Sinovac’s Long-Term Value for All Shareholders Through the Resumption of Trading of Sinovac’s Common Shares
NEW YORK -- (BUSINESS WIRE) --
SAIF Partners IV L.P., (“SAIF Partners”, “we” or “us”), today announced that Sinovac Biotech Ltd. (“Sinovac” or the “Company”) shareholders voted to approve SAIF Partners’ proposals to remove the Company’s incumbent directors and to elect SAIF Partners’ slate of ten highly qualified director nominees to the Board of Directors (the “Board”) at Sinovac’s Special Meeting of Shareholders (the “Special Meeting”).
On July 8, 2025, at 8:00 p.m. Atlantic Standard Time, Sinovac’s incumbent Chairman Chiang Li convened, then immediately purported to adjourn, the Special Meeting without allowing shareholders to participate. SAIF Partners representatives, alongside those of other shareholders, had arrived at the Special Meeting intending to participate in the meeting.
Subsequently, the shareholder representatives present convened a continuation of the Special Meeting, chaired by incumbent Sinovac Director Mr. Yuk Lam Lo, the only remaining director on the incumbent Board approved by Privy Council. During the Special Meeting, Sinovac’s shareholders voted to approve both of SAIF Partners’ proposals, based on a tabulation of votes cast on SAIF Partners’ gold proxy card and the Company’s white proxy card.
The newly elected directors of the Company are committed to supporting and executing Sinovac’s announced payout of dividends and working closely with Sinovac’s management to unlock long-term value for all shareholders by pursuing the resumption of trading of the Company’s common shares to help Sinovac realize its tremendous potential.
About SAIF Partners
SAIF Partners is a leading Asian private equity firm with cumulative assets under management of over $4 billion. SAIF Partners is an active lead investor working closely with its portfolio companies to develop their business both organically and through acquisitions, seeking synergistic cooperation among them, as well as enhancing shareholder value via promotion of good corporate governance and best management practices.
北美首台搭载nLIGHT技术的AMCM M290-2 FLX
Snowplus在疫情期间仍实现全球业务增长
三叶草生物制药启动武汉冠状病毒重组疫苗的研
CNE Direct, Inc 商业名称“illumy
知临集团首席执行官认购本公司股份
书赞桉诺亮相2022年上海纸浆周,用实际行动践
AGC推出不使用表面活性剂及含氟聚合溶剂的创新
DEGIRO将欧洲在线经纪业务零售化
博莱克威奇为使用点制氢提供指导,以推进车辆
袁匡任——2019年最受人民喜爱的艺术家
全球领导人齐聚一堂出席10.14日的2021年全球包容
衡水市公安机关全方位多元化宣传,打好“亮剑
铠侠推出PCIe(R) 4.0 SCM
壳牌新能源部署Beacon Platform以开发
Velodyne Lidar荣获2022年SXSW创新奖
智原科技将于ICCAD 2020展出最新IoT/MCU
米尔肯研究院和莫特赛比基金会启动技术奖励计
中医秉承一脉传 顶礼尚师北京宴
FLIR Systems获得美国国防部4,810万美元合同
遵义电力:当好产业发展的“先行军”
ROSEN鼓励D-MARKET股东聘请律师
水木未来宣布完成天使轮融资
SSA Marine任命Nicolas Gauthie
QpiAI完成650万美元A轮前融资